Military Personnel Overseas: Vaccinations

Lord Coaker Excerpts

Thursday 1st July 2021 Lords Chamber

[Lord Coaker (Lab)]

My Lords, the first priority of government is the protection of and support for our Armed Forces. As the chair of the Defence Select Committee in the other place said, if we vaccinate our Armed Forces personnel for malaria, yellow fever, typhoid and a host of other diseases prior to deployment, why on earth did we not do so for Covid? How many UK military personnel deployed abroad in areas such as Mali contracted Covid, and have operations been affected? Further, the Minister now tells us that 61% of our troops have been fully vaccinated. When will the rest of them—one in three—receive their second dose, and is it not now extremely urgent that they do so?

[The Minister of State, Ministry of Defence (Baroness Goldie) (Con)]

The noble Lord is absolutely right that the safety and well-being of our Armed Forces personnel is paramount. Indeed, that was recognised from the start of the pandemic, when the priority was to keep our Armed Forces safe. There were robust safety measures and regimes in place, and that included isolation prior to deployment.

I reassure the noble Lord that when the commencement of the impressively successful vaccination programme began in December 2020, it allowed the MoD to plan and work in tandem with our domestic vaccination programme. Sometimes we were ahead of that, for good operational reasons. The priority for government has been to save the lives of those most at risk. It is right that we followed the advice of the Joint Committee on Vaccination and Immunisation, which was to prioritise those older age groups and the most at risk first, rather than prioritise by occupation.

The noble Lord asked me about Covid cases among UK Armed Forces on operations. The figures I have been given are current as at 28 June this year, and are that the percentage of UK Armed Forces registering positive for Covid is: in the Persian Gulf, 0.4%; in Iraq, 0.3%; in Mali, 1.4%; in Afghanistan, 1%; and in Estonia, 13.2%. He will be aware that there was a higher case rate in Estonia due to a significant changeover of personnel at the time.

I reassure the noble Lord that second doses will be offered in line with clinical advice and the exact circumstances of the deployment. Our target within defence is four to eight weeks after the first dose, although, where there is an operational requirement, such as overseas deployment, we may accelerate second doses, subject to clinical guidance on the recommended gaps between doses. The only prioritisation that was effected was, as he will be aware, in respect of the nuclear deterrent, the carrier strike group and the rapid response Typhoon force.